- Home
- BBSI vs PHVS Comparison
BBSI vs PHVS Comparison
Compare BBSI & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBSI
- PHVS
- Stock Information
- Founded
- BBSI 1965
- PHVS 2015
- Country
- BBSI United States
- PHVS Switzerland
- Employees
- BBSI N/A
- PHVS N/A
- Industry
- BBSI Professional Services
- PHVS Biotechnology: Pharmaceutical Preparations
- Sector
- BBSI Consumer Discretionary
- PHVS Health Care
- Exchange
- BBSI Nasdaq
- PHVS Nasdaq
- Market Cap
- BBSI 1.1B
- PHVS 980.9M
- IPO Year
- BBSI 1993
- PHVS 2021
- Fundamental
- Price
- BBSI $45.70
- PHVS $20.62
- Analyst Decision
- BBSI Strong Buy
- PHVS Buy
- Analyst Count
- BBSI 2
- PHVS 6
- Target Price
- BBSI $45.00
- PHVS $37.17
- AVG Volume (30 Days)
- BBSI 170.4K
- PHVS 165.3K
- Earning Date
- BBSI 08-06-2025
- PHVS 08-13-2025
- Dividend Yield
- BBSI 0.70%
- PHVS N/A
- EPS Growth
- BBSI 6.65
- PHVS N/A
- EPS
- BBSI 1.96
- PHVS N/A
- Revenue
- BBSI $1,171,315,000.00
- PHVS N/A
- Revenue This Year
- BBSI $9.74
- PHVS N/A
- Revenue Next Year
- BBSI $7.40
- PHVS N/A
- P/E Ratio
- BBSI $23.33
- PHVS N/A
- Revenue Growth
- BBSI 8.41
- PHVS N/A
- 52 Week Low
- BBSI $31.77
- PHVS $11.51
- 52 Week High
- BBSI $46.07
- PHVS $26.33
- Technical
- Relative Strength Index (RSI)
- BBSI 72.57
- PHVS 51.42
- Support Level
- BBSI $43.37
- PHVS $19.95
- Resistance Level
- BBSI $46.07
- PHVS $24.41
- Average True Range (ATR)
- BBSI 0.89
- PHVS 1.87
- MACD
- BBSI 0.27
- PHVS -0.26
- Stochastic Oscillator
- BBSI 90.19
- PHVS 34.41
About BBSI Barrett Business Services Inc.
Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.